FREMONT, Calif.--(BUSINESS WIRE)--DiscoveRx Corporation announces the selection of Cosmo Bio Co., Ltd. as a key distributor for the Japanese territory. “Cosmo Bio’s leadership in providing third party drug discovery services to the Japanese pharmaceutical and biotech industries and in the distribution of products for life science research is well recognized throughout Japan. We believe that the addition of DiscoveRx Corporation’s Selectivity Screen™ GPCR profiling services will significantly benefit Cosmo Bio’s customers,” said Theresa Schaub, Director, Drug Discovery Screening Services at DiscoveRx.
